DaVita Hiring New Chief Financial Officer

Dialysis specialist DaVita HealthCare Partners (NYSE: DVA  ) has a new bean counter.

The Denver-based renal health care specialist announced today that Garry E. Menzel, Ph.D., will join the company in mid-Sptember as senior VP of finance, and will take on the role of chief financial officer the day after the company files its third-quarter report with the SEC. The quarter ends Sept. 30. Jim Hilger, who has served as DaVita's interim CFO since 2012, will continue in his role as the company's chief accounting officer, a position he has held since 2010.

Menzel, 48, was most recently the COO and CFO at biopharmaceutical Regulus Therapeutics, where he served since 2008. Before that, he had a 14-year career on Wall Street where he was a managing director and global head of life sciences for Credit Suisse and of biotechnology for Goldman Sachs. Menzel also spent several years as a strategy consultant for Bain & Company.

Belieiving they've found an executive with a versatile skill set, DaVita HealthCare Partners Co-Chairman and CEO Kent Thiry said, "Given the nimbleness that is required for all health care providers we are excited to have Garry join our leadership team."

DaVita's previous CFO, Luis Borgen, who had been in the position for two years, resigned in April 2012 to take a similar job with loose-leaf tea maker Davids Tea, a privately held VC-backed company.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2526182, ~/Articles/ArticleHandler.aspx, 9/24/2016 10:16:39 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 18,261.45 -131.01 -0.71%
S&P 500 2,164.69 -12.49 -0.57%
NASD 5,305.75 -33.78 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/23/2016 4:02 PM
DVA $66.50 Down -0.22 -0.33%
DaVita CAPS Rating: *****
CS $13.42 Down -0.11 -0.81%
Credit Suisse Grou… CAPS Rating: ***
GS $165.13 Down -2.89 -1.72%
Goldman Sachs CAPS Rating: ***
RGLS $3.45 Up +0.03 +0.88%
Regulus Therapeuti… CAPS Rating: ***